Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0404 per EA under NDC 00172344460. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
12.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00172344460
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA083177On Market Since
6/3/2025
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 34 times since Nov 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0404 per EA |
|---|---|
| All-time high | $0.0412 (Apr 15, 2026) |
| All-time low | $0.0403 (Dec 17, 2025) |
| 52-week high | $0.0412 |
| 52-week low | $0.0403 |
| Median price | $0.0408 |
| Average price | $0.0408 |
| Largest weekly change | +1.3% (Jan 21, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0404 per EA (NDC 00172344460), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has held within roughly two percent of its current level. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Nov 5, 2025, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0403 (Dec 17, 2025) to a high of $0.0412 (Apr 15, 2026), with a median of $0.0408 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0284 per EA — about 30% below HYDROCHLOROTHIAZIDE 12.5 MG TB.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 00172344460) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification